Pneumotox Online
v2.2
  • RSS Feed
  • Contact
  • News
  • Diagnosing DIRD
  • Browse
  • Available on AppStore Available on AppStore

The Drug-Induced Respiratory Disease Website

Philippe Camus, M.D.

Dijon, France

  • Home
  • Browse by »
  • Drugs
  • Patterns

Anorexigens - Anorectic agents - Appetite suppressants

4

VI.b Pulmonary arterial hypertension

4
Last update : 16/10/2012
 
Search
Advanced search
Identify causative drugs
Diagnosing DIRD
1
Drug and radiation history
2
Drug singularity - Correct identification of the drug
3
Consistent timing of exposure v. onset of symptoms
4
Clinical, imaging, BAL, pathological pattern consistent with the specific drug
5
Careful exlusion of another cause
6
Remission of symptoms with removal of drug
7
Recurrence with rechallenge (rarely advisable)
8
Causality assessment
More detailed checklist
See also under
Aminorex
5
Cannabinoids - Cannabinoid receptor agonists (synthetic) (K2, Spice)
5
Dexfenfluramine
3
Dinitrophenol (2, 4-dinitrophenol or DNP)
3
Fenfluramine
3
Levamisole
4
Mazindol
1
Phentermine
3
Thyroid hormones (exogenous)
1

Publications

Changing demographics, epidemiology, and survival of incident pulmonary arterial hypertension: results from the pulmonary hypertension registry of the United Kingdom and Ireland.
American journal of respiratory and critical care medicine 2012 Oct 15;186;790-6 2012 Oct 15
Pulmonary arterial hypertension in a patient with Cowden syndrome and anorexigen exposure.
Chest 2011 Oct;140;1066-1068 2011 Oct
Pulmonary arterial hypertension associated with fenfluramine exposure: report of 109 cases.
The European respiratory journal 2008 Feb;31;343-8 2008 Feb
Anorexigens and pulmonary hypertension in the United States: results from the surveillance of North American pulmonary hypertension.
Chest 2000 Mar;117;870-4 2000 Mar
Primary pulmonary hypertension and anorectic drugs.
The New England journal of medicine 1999 Feb 11;340;480-2 1999 Feb 11
Aminorex, fenfluramine, and chlorphentermine are serotonin transporter substrates. Implications for primary pulmonary hypertension.
Circulation 1999 Aug 24;100;869-75 1999 Aug 24
Primary pulmonary hypertension associated with the use of fenfluramine derivatives.
Chest 1998 Sep;114;195S-199S 1998 Sep
[Development of pulmonary hypertension and multi-valvular damage caused by appetite depressants].
Harefuah 1998 Dec 01;135;489-92, 568 1998 Dec 01
High incidence of primary pulmonary hypertension associated with appetite suppressants in Belgium.
The European respiratory journal 1998 Aug;12;271-6 1998 Aug
Aminorex, dexfenfluramine, and primary pulmonary hypertension.
Journal of clinical epidemiology 1998 Apr;51;361-4 1998 Apr
Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study Group.
The New England journal of medicine 1996 Aug 29;335;609-16 1996 Aug 29

Powered by

  • ^
  • Contact
  • Cookies
  • About

The Pneumotox website uses cookies. By accessing or using our website, you consent to the collection, use and disclosure of the garnered information in accordance with our privacy policy.

Learn more about cookies